ATNF 180 Life Sciences Corp
Price (delayed)
$0.95
Market cap
$4.93M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$15.49
Enterprise value
$495,855
180 Life Sciences Corp. is a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined
Highlights
180 Life Sciences's equity has soared by 148% from the previous quarter
ATNF's debt has dropped by 85% year-on-year and by 68% since the previous quarter
180 Life Sciences's net income has shrunk by 98% QoQ but it has surged by 69% YoY
Key stats
What are the main financial stats of ATNF
Market
Valuations
Earnings
Shares outstanding
5.19M
Market cap
$4.93M
Enterprise value
$495,855
Price to earnings (P/E)
N/A
Price to book (P/B)
0.2
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$6.32M
Net income
-$6.17M
EBIT
-$6.41M
EBITDA
-$6.36M
Free cash flow
-$1.48M
Per share
Balance sheet
Liquidity
EPS
-$15.49
EPS diluted
-$15.49
Free cash flow per share
-$1.62
Book value per share
$4.68
Revenue per share
$0
TBVPS
$5.62
Total assets
$12.76M
Total liabilities
$3.51M
Debt
$154,505
Equity
$9.25M
Working capital
$1.64M
Debt to equity
0.02
Current ratio
1.47
Quick ratio
1.31
Net debt/EBITDA
0.7
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-185.4%
Return on equity
-488.4%
Return on invested capital
N/A
Return on capital employed
-69.3%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ATNF stock price
How has the 180 Life Sciences stock price performed over time
Intraday
-3.07%
1 week
-15.93%
1 month
-18.8%
1 year
-56.82%
YTD
-47.8%
QTD
-3.07%
Financial performance
How have 180 Life Sciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$6.32M
Net income
-$6.17M
Gross margin
N/A
Net margin
N/A
180 Life Sciences's net income has shrunk by 98% QoQ but it has surged by 69% YoY
180 Life Sciences's operating income has surged by 53% YoY
Growth
What is 180 Life Sciences's growth rate over time
Valuation
What is 180 Life Sciences stock price valuation
P/E
N/A
P/B
0.2
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
ATNF's EPS has surged by 71% year-on-year
180 Life Sciences's equity has soared by 148% from the previous quarter
Efficiency
How efficient is 180 Life Sciences business performance
180 Life Sciences's return on equity has increased by 17% YoY and by 13% QoQ
The company's return on assets rose by 10% YoY
Dividends
What is ATNF's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ATNF.
Financial health
How did 180 Life Sciences financials performed over time
The company's total assets has surged by 143% YoY and by 22% QoQ
The current ratio has soared by 104% YoY
ATNF's debt is 98% smaller than its equity
180 Life Sciences's equity has soared by 148% from the previous quarter
ATNF's debt to equity has soared by 100% year-on-year but it has dropped by 85% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.